Home infusion is a growing category and market in the U.S. Home infusion, where alternate-site infusion therapy expenditures are estimated to be $9–11 billion annually. Learn what factors are driving this growth, why many health systems are finding that home infusion pharmacy, as part of a broader specialty pharmacy strategy, aligns with their clinical and financial goals in a value-based care environment, and explore a case study that demonstrates how Excelera helps health systems like Oregon Health & Science University (OHSU) navigate the unique rules, operational complexities, and best practices of home infusion pharmacy.
The Home Infusion market and why home infusion is a growing category.
How many health systems are finding home infusion pharmacy, as part of a broader specialty pharmacy strategy, aligns with their clinical and financial goals.
Adding home infusion pharmacy services can have several positive impacts on health systems, including reduced overall cost of care and superior patient experience.
Home infusion pharmacy has its own set of rules, operational complexities and best practices.
Health systems that use a consultant to help launch home infusion pharmacy can get to market faster as they develop their in-house home infusion expertise.